Skip to content
★ Sign in to follow
Avacta Group PLC logo

Avacta Group PLC Stock: price and insider trades · United Kingdom

ISIN GB00BYYW9G87GB·Mcap £297.6MHealth Care

No insider purchase over the last 90 days. The latest, by Tony Gardiner, was filed 02 Jan 2019.

Avacta Group PLC: what insiders have been doing

Avacta Group PLC belongs to the Health Care sector. Filings by its managers are published through RNS (LSE). Nothing new has been filed by managers of Avacta Group PLC in twelve months, the latest record being from 2 September 2024.

Since 2017, the database holds 5 purchases and 2 sales by insiders of the company.

Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Insider Decl.
18
Thresholds
n/a
Buy Volume
€132,408
5 ops. · all time
Sell Volume
€918,104
2 ops. · all time

Since the insiders bought

  • Filed 02 Jan 2019 · 2867 days ago · €2,772
    -39.5%
    Entry £0.30 · Close at T+365 £0.18
  • Filed 13 Mar 2018 · 3162 days ago · €17k
    -7.4%
    Entry £0.40 · Close at T+365 £0.37
  • Filed 06 Apr 2017 · 3503 days ago · €4,148
    -54.4%
    Entry £0.74 · Close at T+365 £0.34

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Analyst consensus: bullish or bearish?

Analysts rate Avacta Group PLC Hold (neutral), based on 4 analysts. Average price target: £0.93.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

£0.68
Analyst consensus
4 analysts
Hold
£0.55Target £0.93(+37%)£1.22
Income statement
Revenue£113k
Gross profit£113k100% margin
EBITDA-£27.8M-24592% margin
Net income-£38.6M-34169.9% margin
Valuation
PER (forward)-1449.9x
P/Book8500.0x
Beta-0.16
Balance sheet & cash
Market cap£297.6M
Total debt£14.9M
Free Cash Flow-£26.8M
Debt / Equity527%
Profitability & ownership
ROE-1965.1%
ROA-62.4%
% insiders3.2%
% institutions3.1%
Last declaration on 2 September 2024
Declarations18 total
  • ▼
    Chief Financial OfficerExecutives
    355,350 GBP26RNS
    500,000 shares@ £0.710767.4% of flowLondon Stock Exchange, AIM MarketRNS:5332108-2
  • ◆
    Chief Executive OfficerExecutives
    3M GBP30RNS
    3,600,000 shares@ £0.72100.0% of flowOutside a trading venueRNS:5332108-0
  • ◇
    Chief Financial OfficerExecutives
    50,000 GBP20RNS
    500,000 shares@ £0.109.5% of flowOutside a trading venueRNS:5332108-1
  • ◆
    Chief Executive OfficerExecutives
    125,000 GBP30RNS
    1,250,000 shares@ £0.10100.0% of flowOutside a trading venueRNS:4917479-0
  • ◆
    Chief Financial OfficerExecutives
    125,000 GBP21RNS
    1,250,000 shares@ £0.1023.1% of flowOutside a trading venueRNS:4917479-1
  • ●
    Non-Executive ChairmanExecutives
    1,197 GBP0FCA-NSM
    1,260 shares@ £0.95London Stock Exchange, AIM MarketISIN GB00BYYW9G87FCA-NSM:4571280
  • ●
    Non-Executive ChairmanExecutives
    14,250 GBP8FCA-NSM
    15,000 shares@ £0.9514.7% of flowLondon Stock Exchange, AIM MarketISIN GB00BYYW9G87FCA-NSM:4550048
  • ▼
    Chief Executive OfficerExecutives
    448,073 GBP0FCA-NSM
    248,543 shares@ £1.8028London Stock ExchangeISIN GB00BYYW9G87FCA-NSM:3756878
  • ◆
    Chief Executive OfficerExecutives
    486,826 GBP30FCA-NSM
    4,868,260 shares@ £0.1078.9% of flowOutside a trading venueISIN GB00BYYW9G87FCA-NSM:3616654-0
  • ◆
    Chief Financial OfficerExecutives
    145,362 GBP21FCA-NSM
    1,453,620 shares@ £0.1020.5% of flowOutside a trading venueISIN GB00BYYW9G87FCA-NSM:3616654-1
  • ◆
    Chief Executive OfficerExecutives
    174,000 GBP24FCA-NSM
    696,000 shares@ £0.2521.6% of flowOutside a trading venueISIN GB00BYYW9G87FCA-NSM:LSE20190107145049_13926297_20200326185119259_25203-0
  • ◆
    Chief Financial OfficerExecutives
    92,490 GBP20FCA-NSM
    369,960 shares@ £0.2511.5% of flowOutside a trading venueISIN GB00BYYW9G87FCA-NSM:LSE20190107145049_13926297_20200326185119259_25203-1
  • ◆
    Non-executive ChairmanExecutives
    85,000 GBP15FCA-NSM
    340,000 shares@ £0.25100.0% of flowOutside a trading venueISIN GB00BYYW9G87FCA-NSM:LSE20190107145049_13926297_20200326185119259_25203-2
  • ▲
    Chief Financial OfficerExecutives
    2,500 GBP19FCA-NSM
    8,196 shares@ £0.3050.3% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB00BYYW9G87FCA-NSM:LSE20190102070006_13920078_20200326185119525_30577
    Canonical exit: 31 Mar 2019 (T+90)
  • ▲
    Chief Executive OfficerExecutives
    15,007 GBP22FCA-NSM
    35,800 shares@ £0.41921.9% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB00BYYW9G87FCA-NSM:LSE20180313120206_13565172_20200330111427577_18853
    Canonical exit: 11 Jun 2018 (T+90)
  • ▲
    Chief Executive OfficerExecutives
    24,753 GBP22FCA-NSM
    33,225 shares@ £0.7452.7% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB00BYYW9G87FCA-NSM:LSE20170821120028_13336616_20200330131543313_13722
    Canonical exit: 19 Nov 2017 (T+90)
  • ▲
    Chief Executive OfficerExecutives
    72,916 GBP23FCA-NSM
    87,850 shares@ £0.838.1% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB00BYYW9G87FCA-NSM:LSE20170728131528_13311691_20200330131519823_20549
    Canonical exit: 26 Oct 2017 (T+90)
  • ▲
    Non - Executive DirectorExecutives
    3,542 GBP19FCA-NSM
    5,731 shares@ £0.618100.0% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB00BYYW9G87FCA-NSM:LSE20170406102250_13186134_20200330131458535_4448
    Canonical exit: 5 Jul 2017 (T+90)

18 of 18 declarations

About Avacta Group PLC

Avacta Group PLC is a UK-based company focused on developing diagnostic and therapeutic technologies based on proteins. It emphasizes innovation in the healthcare and biotechnology sectors.